1. 1149. Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1). (15th December 2022) Authors: Hedskog, Charlotte; Rodriguez, Lauren; Beigel, John H; Dempsey, Walla; Greninger, Alexander L; Roychoudhury, Pavitra; Huang, Meei-Li; Jerome, Keith R; Hao, Linhui; Ireton, Renee; Gale, Michael; Li, Jiani; Perry, Jason; Han, Dong; Camus, Gregory; Porter, Danielle P Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin. Issue 2 (15th December 2014) Authors: Hedskog, Charlotte; Doehle, Brian; Chodavarapu, Krishna; Gontcharova, Viktoria; Crespo Garcia, Javier; De Knegt, Robert; Drenth, Joost P.H; McHutchison, John G.; Brainard, Diana; Stamm, Luisa M.; Miller, Michael D.; Svarovskaia, Evguenia; Mo, Hongmei Journal: Hepatology Issue: Volume 61:Issue 2(2015:Feb.) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hepatitis B virus genome diversity in adolescents: Tenofovir disoproxil fumarate treatment effect and HBeAg serocon version. Issue 8 (8th June 2021) Authors: Combet, Christophe; Bhardwaj, Neeru; Hedskog, Charlotte; Podlaha, Ondrej; Gaggar, Anuj; Murray, Karen F.; Mo, Hongmei; Svarovskaia, Evguenia; Zoulim, Fabien Journal: Journal of viral hepatitis Issue: Volume 28:Issue 8(2021) Page Start: 1160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HIV co‐infection is associated with increased transmission risk in patients with chronic hepatitis C virus. Issue 11 (4th July 2019) Authors: Ragonnet‐Cronin, Manon; Hostager, Reilly; Hedskog, Charlotte; Osinusi, Ana; Svarovskaia, Eugenia; Wertheim, Joel O. Journal: Journal of viral hepatitis Issue: Volume 26:Issue 11(2019) Page Start: 1351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification. (22nd February 2019) Authors: Hedskog, Charlotte; Parhy, Bandita; Chang, Silvia; Zeuzem, Stefan; Moreno, Christophe; Shafran, Stephen D; Borgia, Sergio M; Asselah, Tarik; Alric, Laurent; Abergel, Armand; Chen, Jyh-Jou; Collier, Jane; Kapoor, Dharmesh; Hyland, Robert H; Simmonds, Peter; Mo, Hongmei; Svarovskaia, Evguenia S Journal: Open forum infectious diseases Issue: Volume 6:Number 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes. (30th June 2018) Authors: Borgia, Sergio M; Hedskog, Charlotte; Parhy, Bandita; Hyland, Robert H; Stamm, Luisa M; Brainard, Diana M; Subramanian, Mani G; McHutchison, John G; Mo, Hongmei; Svarovskaia, Evguenia; Shafran, Stephen D Journal: Journal of infectious diseases Issue: Volume 218:Number 11(2018) Page Start: 1722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia. (2nd September 2017) Authors: Zakalashvili, Mamuka; Zarkua, Jaba; Weizenegger, Michael; Bartel, Jan; Raabe, Monika; Zangurashvili, Lela; Kankia, Nino; Jashiashvili, Nino; Lomidze, Maka; Telia, Tengiz; Kerashvili, Vakhtang; Zhamutashvili, Maia; Abramishvili, Nikoloz; Hedskog, Charlotte; Chodavarapu, Krishna; Brainard, Diana M.... Journal: Liver international Issue: Volume 38:Number 3(2018) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-Term Persistence of HCV NS5A Resistance-Associated Substitutions after Treatment with the HCV NS5A Inhibitor, Ledipasvir, without Sofosbuvir. Issue 3 (April 2018) Authors: Wyles, David; Mangia, Alessandra; Cheng, Wendy; Shafran, Stephen; Schwabe, Christian; Ouyang, Wen; Hedskog, Charlotte; McNally, John; Brainard, Diana M; Doehle, Brian P; Svarovskaia, Evguenia; Miller, Michael D; Mo, Hongmei; Dvory-Sobol, Hadas Journal: Antiviral therapy Issue: Volume 23:Issue 3(2018) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prevalence of resistance-associated substitutions and phylogenetic analysis of hepatitis C virus infection in Russia. (December 2021) Authors: Isakov, Vasily; Hedskog, Charlotte; Wertheim, Joel O.; Hostager, Reilly E.; Parhy, Bandita; Schneider, Adriano De Bernardi; Suri, Vithika; Mo, Hongmei; Geivandova, Natalia; Morozov, Vyacheslav; Bessonova, Elena; Gankina, Natalya; Zhdanov, Konstantin; Abdurakhmanov, Dzhamal; Svarovskaia, Evguenia Journal: International journal of infectious diseases Issue: Volume 113(2021) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan. Issue 1 (16th September 2020) Authors: Mizokami, Masashi; Liu, Lauren J.; Fujiyama, Naoto; Littman, Marcus; Yuan, Jason; Sekiya, Tomoko; Hedskog, Charlotte; Ng, Leslie J. Journal: Journal of viral hepatitis Issue: Volume 28:Issue 1(2021) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗